Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of preparation method of cobicistat intermediate and its intermediate and application

A technology for intermediates and uses, applied in the field of pharmaceutical chemical synthesis, can solve the problems of increased by-products, unsuitable for industrial production, and reduced reaction yields, and achieves the effects of improving yields, being beneficial to environmental maintenance, and reducing side reactions.

Active Publication Date: 2017-10-31
ZHEJIANG YONGNING PHARMA
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009] However, the compound (22) generated in this route is symmetrical on both sides, and there is no protecting group on the amino group. The amino groups on both sides are easily replaced at the same time, which increases the by-products and reduces the reaction yield; the second step of the reaction requires the use of newly prepared Highly toxic sodium amalgam - made by heating mercury to 150-200°C and adding small pieces of sodium, not suitable for industrial production

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of preparation method of cobicistat intermediate and its intermediate and application
  • A kind of preparation method of cobicistat intermediate and its intermediate and application
  • A kind of preparation method of cobicistat intermediate and its intermediate and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0064] Embodiment 1. Synthesis of compound 8a

[0065]

[0066] Add compound 9a (20g, 1.0eq.), compound 10 (34.4g, 1.1eq.) into dichloromethane (240ml), stir at room temperature under nitrogen protection to obtain a clear solution. Diisopropylethylamine (17.3 g, 1.2 eq.) was added dropwise to the mixture. After the addition was complete, the reaction was kept at temperature until the raw material 9a was consumed. The reaction solution was washed successively with 1N hydrochloric acid (80ml), saturated sodium bicarbonate (80ml) and saturated brine (80ml), and dried over anhydrous sodium sulfate. After filtration, the filtrate was evaporated to remove the organic solvent under reduced pressure, and the crude solid obtained was slurried with tert-butyl methyl ether (MTBE) (70ml) for half an hour, and then filtered. The obtained precipitate was dried to obtain compound 8a (32.3 g, yield 90%).

Embodiment 2

[0067] Embodiment 2. Synthesis of compound 8b

[0068]

[0069] Compound 9a (20g, 1.0eq.), Boc-anhydride (26.8g, 1.1eq.) was added into dichloromethane (240ml), stirred at room temperature under nitrogen protection to obtain a clear solution. Diisopropylethylamine (5.4 g, 1.2 eq.) was added dropwise to the mixture, and the dropwise addition was completed, and the reaction was maintained until the raw material 9a was consumed. The reaction solution was washed successively with 1N hydrochloric acid (80ml), saturated sodium bicarbonate (80ml) and saturated brine (80ml), and dried over anhydrous sodium sulfate. After filtration, the filtrate was evaporated to remove the organic solvent under reduced pressure, and the crude solid obtained was slurried with tert-butyl methyl ether (MTBE) (70ml) for half an hour, and then filtered. The obtained precipitate was dried to obtain compound 8b (30.1 g, yield 96%).

Embodiment 3

[0070] Embodiment 3. Synthesis of compound 7a

[0071]

[0072] Compound 8a (32g, 1.0eq.) and lithium chloride (8.5g, 2.0eq.) were added into methanol (500ml), stirred and dissolved under nitrogen protection until clear. The mixture was cooled to below 5°C in an ice-water bath, sodium borohydride (7.5 g, 2.0 eq.) was added to the reaction solution in batches, and the reaction solution was kept at room temperature for reaction after addition. The reaction was monitored by TLC until the starting material disappeared. The reaction solution was placed in an ice-water bath to cool down to below 5°C, 15ml of water was added dropwise to the mixture, and then 2N hydrochloric acid was added dropwise until the pH was 2-3. Most of the solvent was evaporated, the residue was adjusted to pH 9 with 2mol / L NaOH solution, the aqueous layer was washed with dichloromethane (30ml x 3), the combined organic layers were washed with water (30ml) and saturated brine (30ml), anhydrous sulfuric ac...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the field of medicinal chemical synthesis, in particular to a preparation method of a cobicistat intermediate, an intermediate and an application thereof. The present invention provides a preparation method of cobicistat intermediate (compound 4), said method is to make compound (5) into organometallic compound (5'), compound (5') reacts with compound 6 to prepare compound (4): The present invention obtains a new method for preparing compound (4) by providing a new reaction raw material compound (5) or compound (6). This method can not only improve the overall yield of the reaction, but also The method avoids the use of toxic reagents, reduces the occurrence of side reactions, and is suitable for industrial production. Furthermore, the preparation of compound (1) using compound (4) as an intermediate avoids the by-products in the prior art, avoids the use of toxic reagents, saves costs, and is particularly beneficial to environmental maintenance and is suitable for industrial production.

Description

technical field [0001] The invention relates to the field of medicinal chemical synthesis, in particular to a preparation method of a cobicistat intermediate, an intermediate and an application thereof. Background technique [0002] Cobicistat is a CYP3A inhibitor that is used in combination with other antiretroviral drugs to treat HIV-1 infection. It was developed by Gilead and was approved by the FDA on September 24, 2014. The trade name is Tybost. Among them, the compound thiazol-5-ylmethyl ((2R,5R)-5-amino-1,6-diphenylhexan-2-yl) carbamate is a fragment of cobicistat, and its structural formula is as follows: [0003] [0004] Following compound (4) is a key intermediate for preparing compound (1), and its structure is: [0005] [0006] Wherein, any selected from (5-thiazolyl) methoxycarbonyl or amino protecting group, R 1 and R 2 are different from each other, and R 1 and R 2 It is not an amino protecting group at the same time. [0007] Patent CN101679325 ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07D277/24C07C271/14C07C271/18
CPCY02P20/55
Inventor 叶天健陆修伟刘永江王彤舒展
Owner ZHEJIANG YONGNING PHARMA